Champions Oncology Inc. (CSBR) NASDAQ
$6.30 0.02 (0.32%)
Market Cap: $84.65M
As of 10/04/23 04:00 PM EDT. Market closed.
Champions Oncology Inc. (CSBR)
NASDAQ
$6.30
0.02 (0.32%)
Market Cap: $84.65M
As of 10/04/23 04:00 PM EDT. Market closed.
champions oncology, inc. is engaged in the development of advanced technology solutions to personalize the development and use of oncology drugs. champions tumorgraft™ technology platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments, or tumorgrafts, in a manner that ... read more
champions oncology, inc. is engaged in the development of advanced technology solutions to personalize the development and use of oncology drugs. champions tumorgraft™ technology platform is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune deficient mice followed by propagation of the resulting engraftments, or tumorgrafts, in a manner that preserves the biological characteristics of the original human tumor. champions believes that these tumorgrafts, unlike cell line derived xenografts used in tradition testing, closely reflect human cancer biology and their response to drugs is predictive of clinical outcomes in cancer patients. the company offers personalized tumorgraft development, drug studies and genome sequencing as part of its personalized oncology solutions ("pos") whereby physicians can evaluate the effects of cancer drugs on their patients' tumorgrafts and understand the genetic make-up of their patient's tumor enabling them read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Full Time Employees
198
Address
855 N Wolfe St Ste 619, Maryland, Baltimore, 21205-1511.
PRICE CHART FOR CHAMPIONS ONCOLOGY INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$6.40
Previous Close
$6.28
Days Range
$6.19 - $6.64
52 week range
$3.75 - $7.89
Volume
14,075
Avg. Volume (30 days)
12,224
Market Cap
$84.65M
Dividend Yield
-
P/E
-
Shares Outstanding
13,479,215
Open
$6.40
Previous Close
$6.28
Days Range
$6.19 - $6.64
52 week range
$3.75 - $7.89
Volume
14,075
Avg. Volume (30 days)
12,224
Market Cap
$84.65M
Dividend Yield
-
P/E
-
Shares Outstanding
13,479,215
FINANCIAL STATEMENTS FOR CHAMPIONS ONCOLOGY INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR CHAMPIONS ONCOLOGY INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Mendelson Daniel Newman | Director | Oct 03, 2023 | Buy | $6.30 | 2,500 | 15,750 | 148,451 | Oct 04, 2023, 05:31 PM |
| Mendelson Daniel Newman | Director | Oct 04, 2023 | Buy | $6.40 | 5,000 | 32,000 | 153,451 | Oct 04, 2023, 05:30 PM |
| Mendelson Daniel Newman | Director | Sep 26, 2023 | Buy | $5.65 | 5,000 | 28,250 | 145,951 | Sep 27, 2023, 09:56 AM |
| Mendelson Daniel Newman | Director | Sep 19, 2023 | Buy | $5.28 | 5,000 | 26,400 | 128,121 | Sep 25, 2023, 03:00 PM |
| Mendelson Daniel Newman | Director | Sep 20, 2023 | Buy | $5.51 | 4,018 | 22,139 | 132,139 | Sep 25, 2023, 02:59 PM |
| Mendelson Daniel Newman | Director | Sep 21, 2023 | Buy | $5.51 | 5,000 | 27,550 | 137,139 | Sep 25, 2023, 02:59 PM |
| Mendelson Daniel Newman | Director | Sep 22, 2023 | Buy | $5.50 | 3,812 | 20,966 | 140,951 | Sep 25, 2023, 02:59 PM |
| Morris Ronnie | CEO | Mar 17, 2023 | Buy | $4.04 | 12,382 | 49,969 | 858,878 | Mar 21, 2023, 12:30 PM |
| ACKERMAN JOEL | Director | Oct 19, 2022 | Option Exercise | $3.21 | 16,667 | 53,501 | 1,460,595 | Oct 20, 2022, 01:26 PM |
| SIDRANSKY DAVID | Director | Oct 12, 2022 | Option Exercise | $7.51 | 3,562 | 26,751 | 767,043 | Oct 14, 2022, 02:27 PM |
| SIDRANSKY DAVID | Director | Oct 12, 2022 | Option Exercise | $3.21 | 8,333 | 26,749 | 770,605 | Oct 14, 2022, 02:27 PM |
| Breitfeld Philip P. | Director | Oct 12, 2022 | Option Exercise | $7.51 | 3,562 | 26,751 | 14,638 | Oct 14, 2022, 02:25 PM |
| Breitfeld Philip P. | Director | Oct 12, 2022 | Option Exercise | $3.21 | 8,333 | 26,749 | 18,200 | Oct 14, 2022, 02:25 PM |
| TOBIN SCOTT R | Director | Oct 12, 2022 | Option Exercise | $3.21 | 10,000 | 32,100 | 30,000 | Oct 13, 2022, 09:00 AM |
| SIDRANSKY DAVID | Director | Oct 15, 2021 | Option Exercise | $10.08 | 2,629 | 26,500 | 762,272 | Oct 19, 2021, 03:39 PM |
| SIDRANSKY DAVID | Director | Oct 15, 2021 | Option Exercise | $1.59 | 16,667 | 26,501 | 764,901 | Oct 19, 2021, 03:39 PM |
| TOBIN SCOTT R | Director | Oct 12, 2021 | Option Exercise | $1.59 | 10,000 | 15,900 | 20,000 | Oct 13, 2021, 10:26 AM |
| Breitfeld Philip P. | Director | Mar 23, 2021 | Option Exercise | $11.35 | 1,340 | 15,209 | 2,827 | Mar 25, 2021, 03:27 PM |
| Breitfeld Philip P. | Director | Mar 23, 2021 | Option Exercise | $3.65 | 4,167 | 15,210 | 4,167 | Mar 25, 2021, 03:27 PM |
| Poliakoff Abba David | Director | Jan 19, 2021 | Option Exercise | $11.53 | 8,873 | 102,306 | 81,274 | Feb 08, 2021, 04:46 PM |
| Poliakoff Abba David | Director | Jan 19, 2021 | Option Exercise | $3.41 | 30,000 | 102,300 | 90,147 | Feb 08, 2021, 04:46 PM |
| Breitfeld Philip P. | Director | Dec 16, 2020 | Sale | $11.35 | 31,443 | 356,976 | 0 | Dec 17, 2020, 09:29 AM |
| ACKERMAN JOEL | Director | Mar 03, 2020 | Option Exercise | $5.74 | 126,940 | 728,575 | 1,443,928 | Nov 03, 2020, 05:46 PM |
| Mendelson Daniel Newman | Director | Feb 18, 2020 | Option Exercise | $3.42 | 30,000 | 102,600 | 123,121 | Nov 03, 2020, 05:44 PM |
| Mendelson Daniel Newman | Director | Feb 11, 2020 | Option Exercise | $5.76 | 34,375 | 198,000 | 103,121 | Nov 03, 2020, 05:39 PM |
| Morris Ronnie | CEO | Mar 11, 2020 | Option Exercise | $5.74 | 126,940 | 728,575 | 964,108 | Nov 03, 2020, 05:38 PM |
| TOBIN SCOTT R | Director | Oct 30, 2020 | Option Exercise | $5.46 | 10,000 | 54,600 | 10,000 | Oct 30, 2020, 04:36 PM |
| SIDRANSKY DAVID | Director | Oct 16, 2020 | Option Exercise | $9.01 | 10,100 | 91,001 | 748,234 | Oct 28, 2020, 02:53 PM |
| SIDRANSKY DAVID | Director | Oct 16, 2020 | Option Exercise | $5.46 | 16,667 | 91,002 | 758,334 | Oct 28, 2020, 02:53 PM |
| Mendelson Daniel Newman | Director | Mar 26, 2020 | Buy | $5.91 | 1,220 | 7,213 | 58,746 | Mar 30, 2020, 04:56 PM |
| Mendelson Daniel Newman | Director | Mar 24, 2020 | Buy | $5.50 | 26 | 143 | 57,526 | Mar 26, 2020, 03:00 PM |
| Morris Ronnie | CEO | Mar 24, 2020 | Sale | $5.25 | 75 | 394 | 837,168 | Mar 26, 2020, 02:52 PM |
| Morris Ronnie | CEO | Mar 20, 2020 | Buy | $4.75 | 75 | 356 | 837,243 | Mar 24, 2020, 09:54 AM |
| Battery Ventures IX, L.P. | 10% Owner | Mar 11, 2020 | Option Exercise | $5.47 | 409,791 | 2,241,997 | 2,421,673 | Mar 12, 2020, 02:03 PM |
| New Enterprise Associates 14, L.P. | 10% Owner | Mar 06, 2020 | Sale | $6.99 | 708,155 | 4,950,003 | 1,713,720 | Mar 10, 2020, 04:45 PM |
| New Enterprise Associates 14, L.P. | 10% Owner | Mar 06, 2020 | Option Exercise | $5.76 | 859,375 | 4,950,000 | 2,421,875 | Mar 10, 2020, 04:45 PM |
| ACKERMAN JOEL | Director | Dec 02, 2019 | Option Exercise | $2.10 | 203,111 | 426,533 | 1,316,988 | Dec 04, 2019, 04:10 PM |
| Battery Ventures IX, L.P. | 10% Owner | Jan 08, 2019 | Option Exercise | $4.80 | 58,333 | 279,998 | 2,011,882 | Apr 30, 2019, 04:30 PM |
| Morris Ronnie | CEO | Jan 16, 2019 | Option Exercise | $4.80 | 4,167 | 20,002 | 837,168 | Jan 16, 2019, 03:39 PM |
| ACKERMAN JOEL | Director | Jan 02, 2019 | Option Exercise | $4.80 | 4,167 | 20,002 | 1,113,877 | Jan 04, 2019, 03:01 PM |
| Morris Ronnie | CEO | Dec 19, 2018 | Buy | $7.44 | 20,000 | 148,800 | 833,001 | Dec 20, 2018, 03:18 PM |
| Mendelson Daniel Newman | Director | Nov 06, 2018 | Sale | $13.75 | 5,000 | 68,750 | 57,500 | Nov 08, 2018, 05:02 PM |
| Morris Ronnie | CEO | Oct 11, 2018 | Option Exercise | $12.34 | 303,581 | 3,746,190 | 813,001 | Oct 15, 2018, 02:05 PM |
| ACKERMAN JOEL | Director | Oct 12, 2018 | Option Exercise | $17.47 | 12,021 | 210,007 | 1,109,710 | Oct 12, 2018, 02:45 PM |
| ACKERMAN JOEL | Director | Oct 12, 2018 | Option Exercise | $2.10 | 100,000 | 210,000 | 1,121,731 | Oct 12, 2018, 02:45 PM |
| Mendelson Daniel Newman | Director | Sep 20, 2018 | Sale | $13.02 | 8,333 | 108,496 | 62,500 | Oct 05, 2018, 10:30 AM |
| ACKERMAN JOEL | Director | Oct 01, 2018 | Sale | $17.02 | 22,535 | 383,546 | 1,021,731 | Oct 03, 2018, 10:22 AM |
| Morris Ronnie | CEO | Mar 26, 2018 | Buy | $3.57 | 2,235 | 7,979 | 1,114,282 | Mar 28, 2018, 05:26 PM |
| Morris Ronnie | CEO | Mar 27, 2018 | Buy | $3.62 | 2,300 | 8,319 | 1,116,582 | Mar 28, 2018, 05:26 PM |
| Morris Ronnie | CEO | Mar 23, 2018 | Buy | $3.50 | 440 | 1,540 | 1,111,847 | Mar 26, 2018, 04:05 PM |
| Morris Ronnie | CEO | Mar 22, 2018 | Buy | $3.49 | 260 | 907 | 1,112,047 | Mar 26, 2018, 04:05 PM |
| Morris Ronnie | President | Oct 21, 2016 | Buy | $1.66 | 30,000 | 49,900 | 1,111,347 | Oct 24, 2016, 02:05 PM |
| Morris Ronnie | President | Oct 19, 2016 | Buy | $1.70 | 10,000 | 17,000 | 1,081,347 | Oct 20, 2016, 04:35 PM |
| ACKERMAN JOEL | Chief Executive Officer | Oct 18, 2016 | Buy | $1.70 | 2,000 | 3,393 | 1,044,266 | Oct 20, 2016, 11:13 AM |
| Morris Ronnie | President | Oct 14, 2016 | Buy | $1.66 | 10,305 | 17,106 | 1,071,347 | Oct 17, 2016, 09:54 AM |
| ACKERMAN JOEL | Chief Executive Officer | Oct 14, 2016 | Buy | $1.66 | 1,300 | 2,153 | 1,042,266 | Oct 14, 2016, 04:40 PM |
| ACKERMAN JOEL | Chief Executive Officer | Oct 13, 2016 | Buy | $1.68 | 6,000 | 10,052 | 1,040,966 | Oct 14, 2016, 04:40 PM |
| Morris Ronnie | President | Oct 13, 2016 | Buy | $1.67 | 29,695 | 49,494 | 1,061,042 | Oct 14, 2016, 01:09 PM |
| Morris Ronnie | President | Oct 10, 2016 | Buy | $1.66 | 9,537 | 15,831 | 1,031,347 | Oct 11, 2016, 10:38 AM |
| ACKERMAN JOEL | Chief Executive Officer | Oct 06, 2016 | Buy | $1.61 | 3,202 | 5,169 | 1,029,966 | Oct 07, 2016, 02:18 PM |
| ACKERMAN JOEL | Chief Executive Officer | Oct 07, 2016 | Buy | $1.64 | 5,000 | 8,200 | 1,034,966 | Oct 07, 2016, 02:18 PM |
| ACKERMAN JOEL | Chief Executive Officer | Sep 23, 2016 | Buy | $1.65 | 33 | 54 | 1,026,764 | Sep 26, 2016, 04:24 PM |
| Morris Ronnie | President | Sep 20, 2016 | Buy | $1.58 | 3,000 | 4,740 | 1,021,810 | Sep 21, 2016, 02:27 PM |
| ACKERMAN JOEL | Chief Executive Officer | Sep 21, 2016 | Buy | $1.71 | 2,000 | 3,429 | 1,026,731 | Sep 21, 2016, 02:26 PM |
| ACKERMAN JOEL | Chief Executive Officer | Sep 20, 2016 | Buy | $1.63 | 3,000 | 4,895 | 1,024,731 | Sep 21, 2016, 02:26 PM |
| Morris Ronnie | President | Jul 21, 2016 | Option Exercise | $4.55 | 94,564 | 430,266 | 3,737,564 | Sep 14, 2016, 03:28 PM |
| BROWN MICHAEL MAURICE | 10% Owner | Mar 11, 2015 | Buy | $0.40 | 6,250,000 | 2,500,000 | 22,281,040 | Mar 13, 2015, 08:15 PM |
| Battery Ventures IX, L.P. | 10% Owner | Mar 11, 2015 | Buy | $0.40 | 6,250,000 | 2,500,000 | 22,281,040 | Mar 13, 2015, 07:47 PM |
| Mendelson Daniel Newman | Director | Mar 20, 2014 | Buy | $1.08 | 97,500 | 105,300 | 100,000 | Mar 21, 2014, 05:27 PM |
| Mendelson Daniel Newman | Director | Mar 19, 2014 | Buy | $1.05 | 2,500 | 2,620 | 2,500 | Mar 21, 2014, 05:27 PM |
| Morris Ronnie | President | Mar 19, 2014 | Buy | $1.07 | 100,000 | 106,990 | 961,648 | Mar 21, 2014, 02:36 PM |
| BROWN MICHAEL MAURICE | 10% Owner | Jan 28, 2013 | Buy | $0.50 | 7,000,000 | 3,500,000 | 15,566,667 | Jan 30, 2013, 05:01 PM |
| Morris Ronnie | President | Jan 28, 2013 | Buy | $0.50 | 500,000 | 250,000 | 833,333 | Jan 30, 2013, 05:00 PM |
| ACKERMAN JOEL | Chief Executive Officer | Jan 28, 2013 | Buy | $0.50 | 500,000 | 250,000 | 833,333 | Jan 30, 2013, 04:58 PM |
| Battery Ventures IX, L.P. | 10% Owner | Jan 28, 2013 | Buy | $0.50 | 7,000,000 | 3,500,000 | 15,566,667 | Jan 30, 2013, 04:54 PM |
| Poliakoff Abba David | Director | Jan 09, 2012 | Option Exercise | $0.75 | 11,333 | 8,500 | 588,667 | Jun 07, 2012, 03:47 PM |
| Poliakoff Abba David | Director | Jan 09, 2012 | Option Exercise | $0.17 | 50,000 | 8,500 | 600,000 | Jun 07, 2012, 03:47 PM |
| Martell James | Director | Jun 21, 2011 | Sale | $0.63 | 3,100,000 | 1,953,000 | 2,051,828 | Jun 23, 2011, 07:35 AM |
| Martell James | Director | Apr 05, 2011 | Sale | $0.48 | 2,000,000 | 960,000 | 5,151,828 | Apr 06, 2011, 10:34 AM |
| Martell James | Director | Sep 07, 2010 | Sale | $0.44 | 93,921 | 41,325 | 7,151,828 | Sep 08, 2010, 01:16 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN CHAMPIONS ONCOLOGY INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 124,891 | 0.00115% | -1.26% | Other |
| BLACKROCK INC. | 117,139 | 0.00002% | 1.12% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 58,916 | 0.00004% | 16.78% | Other |
CHANGE IN SHARES OUTSTANDING FOR CHAMPIONS ONCOLOGY INC
STOCK BUYBACKS FOR CHAMPIONS ONCOLOGY INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 07/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
04/30/2023
-0.45%
1Q
01/31/2023
-0.38%
2Q
10/31/2022
-0.16%
3Q
07/31/2022
-0.12%
4Q
04/30/2022
-4.24%
5Q
01/31/2022
-6.12%
6Q
10/31/2021
-7.16%
7Q
07/31/2021
0.78%
8Q
04/30/2021
-8.51%
9Q
01/31/2021
-6.90%
10Q
10/31/2020
-10.33%
11Q
07/31/2020
-5.09%
12Q
04/30/2020
14.04%
13Q
01/31/2020
-1.22%
14Q
10/31/2019
4.18%
15Q
07/31/2019
16.24%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR CHAMPIONS ONCOLOGY INC
LOADING...